Sponsor pipeline

Boryung Pharmaceutical Co., Ltd clinical trial pipeline

Get alerts when Boryung Pharmaceutical Co., Ltd's trials change

23 active trials 15 recruiting 11 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Phase 1
8
Phase 2
3
Phase 4
1
Not charted: 11 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06972732 A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose… Type 2 Diabetes Recruiting 2025-09-15
Phase 2
NCT06821945 A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in… Schizophrenia Recruiting 2025-09-15
NCT07180771 A Study of Bosmolisib (BR101801) in Participants With R/R PTCL. Peripheral T Cell Lymphoma Not Yet Recruiting 2026-01-28
NCT07373613 A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With… Essential Hypertension Not Yet Recruiting 2026-01-28
Phase 1
NCT07083388 A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and… Diabetes Mellitus Recruiting 2025-07-24
NCT07083401 A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and… Diabete Mellitus Recruiting 2025-07-24
NCT07069335 A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in… Ovarian Cancer Recruiting 2025-07-16
NCT06867497 A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety… Metastatic Adenocarcinoma of the Pancreas Recruiting 2025-04-10
NCT07421375 A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A… Essential Hypertension Not Yet Recruiting 2026-02-19
NCT07421388 A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A… Essential Hypertension Not Yet Recruiting 2026-02-19
NCT07421401 A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A… Essential Hypertension Not Yet Recruiting 2026-02-19
NCT07421414 A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A… Essential Hypertension Not Yet Recruiting 2026-02-19
Not specified
NCT07263178 A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic… Metastatic Colorectal Cancer Recruiting 2025-12-04
NCT07263191 A Study of Olanzapine in Participants With Bipolar Disorder. Bipolar Disorder Recruiting 2025-12-04
NCT06021483 Observational Study to Evaluate the Safety and Efficacy of Zepzelca™ Injection SCLC Recruiting 2025-09-16
NCT05970237 A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2… Diabetes Mellitus Recruiting 2025-09-15
NCT05413057 An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or… Hypertension,Essential Recruiting 2025-09-12
NCT06314919 A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of… Primary Hypercholesterolemia Recruiting 2025-09-12
NCT06537752 A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients Breast Cancer Recruiting 2025-09-12
NCT06126016 A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj. Chronic Kidney Disease 5D Recruiting 2024-12-12
NCT06649162 A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients… Type 2 Diabetes Recruiting 2024-10-18
NCT07685054 To Evaluate the Renal Protective Effects and Safety of 'Fimasartan and Atorvastatin' or… Essential Hypertension Not Yet Recruiting 2026-07-06
NCT04416490 Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer Stage II Colon Cancer Active, Not Recruiting 2025-09-12

Disease areas by active trials, top 10 of 11

Get alerts when Boryung Pharmaceutical Co., Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free